Larimar Therapeutics, Inc. (LRMR)
3.32
-0.54
(-14.10%)
USD |
NASDAQ |
Sep 24, 16:00
3.32
0.00 (0.00%)
After-Hours: 19:59
Larimar Therapeutics Price : 3.32 for Sept. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 24, 2026 | 3.85 | 3.86 | 3.305 | 3.32 | 3.633M |
| Sep 23, 2026 | 3.82 | 3.90 | 3.71 | 3.865 | 2.719M |
| Sep 22, 2026 | 3.91 | 3.965 | 3.815 | 3.82 | 702938.0 |
| Sep 21, 2026 | 3.84 | 3.885 | 3.78 | 3.83 | 579330.0 |
| Sep 18, 2026 | 3.81 | 3.88 | 3.75 | 3.79 | 1.641M |
| Sep 17, 2026 | 3.93 | 4.12 | 3.80 | 3.80 | 1.196M |
| Sep 16, 2026 | 3.93 | 3.97 | 3.825 | 3.93 | 1.958M |
| Sep 15, 2026 | 3.86 | 3.94 | 3.70 | 3.91 | 856618.0 |
| Sep 14, 2026 | 3.93 | 3.98 | 3.74 | 3.78 | 1.169M |
| Sep 11, 2026 | 3.91 | 4.07 | 3.85 | 3.92 | 2.127M |
| Sep 10, 2026 | 3.82 | 3.86 | 3.74 | 3.85 | 871388.0 |
| Sep 09, 2026 | 4.03 | 4.17 | 3.83 | 3.87 | 978796.0 |
| Sep 08, 2026 | 3.76 | 4.08 | 3.72 | 4.075 | 1.041M |
| Sep 04, 2026 | 3.82 | 3.85 | 3.79 | 3.83 | 391990.0 |
| Sep 03, 2026 | 3.90 | 3.90 | 3.774 | 3.83 | 684259.0 |
| Sep 02, 2026 | 3.96 | 4.075 | 3.822 | 3.87 | 515555.0 |
| Sep 01, 2026 | 3.78 | 3.95 | 3.77 | 3.94 | 755350.0 |
| Aug 31, 2026 | 3.98 | 4.00 | 3.81 | 3.82 | 1.066M |
| Aug 28, 2026 | 4.03 | 4.08 | 3.98 | 4.01 | 641506.0 |
| Aug 27, 2026 | 4.16 | 4.16 | 4.02 | 4.05 | 673588.0 |
| Aug 26, 2026 | 4.14 | 4.18 | 4.02 | 4.17 | 702136.0 |
| Aug 25, 2026 | 4.08 | 4.235 | 4.08 | 4.16 | 1.082M |
| Aug 24, 2026 | 4.23 | 4.23 | 3.93 | 4.05 | 945555.0 |
| Aug 21, 2026 | 4.20 | 4.21 | 4.085 | 4.18 | 699420.0 |
| Aug 20, 2026 | 4.21 | 4.21 | 3.975 | 4.16 | 1.158M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 22.18 |
| Alnylam Pharmaceuticals, Inc. | 249.59 |
| Anika Therapeutics, Inc. | 20.23 |
| Savara, Inc. | 5.07 |
| Vericel Corp. | 39.30 |
Price Related Metrics
| PEG Ratio | -0.062 |
| Price to Book Value | 2.721 |
| Earnings Yield | -59.73% |
| Market Cap | 346.55M |
| PEGY Ratio | -0.062 |